Capra Biosciences, Inc.
Capra Biosciences is revolutionizing chemical production with patented bioreactor technology that creates high-performance renewable chemicals using natural processes. Their mission is to make high-performance renewable chemicals cost-efficient and sustainable by transforming waste into valuable materials through biological manufacturing. They focus on sustainable, bio-based chemicals, leveraging biofilms and innovative bioreactor designs to produce complex hydrophobic products like retinol, a form of vitamin A used in cosmetics. The company aims to support the U.S. biomanufacturing sector, reduce reliance on petrochemicals, and enable distributed manufacturing.
Industries
Nr. of Employees
small (1-50)
Capra Biosciences, Inc.
101 International Drive, STE 100, Sterling VA, 20166
Products
Retinol produced via biofilm bioreactor (petroleum-free)
A bio-derived retinol produced using a biofilm-based bioreactor and integrated extraction process, positioned as a renewable alternative to petrochemical synthesis for cosmetic applications.
Retinol produced via biofilm bioreactor (petroleum-free)
A bio-derived retinol produced using a biofilm-based bioreactor and integrated extraction process, positioned as a renewable alternative to petrochemical synthesis for cosmetic applications.
Services
Project-based demonstration using a modular biofilm bioreactor platform to develop and produce biologically derived small-molecule APIs at pilot scale, including AI-assisted design and partner coordination.
Development and scale-up services using biofilm-based reactors and integrated extraction workflows to produce hydrophobic commodity and specialty chemicals from renewable feedstocks.
Project-based demonstration using a modular biofilm bioreactor platform to develop and produce biologically derived small-molecule APIs at pilot scale, including AI-assisted design and partner coordination.
Development and scale-up services using biofilm-based reactors and integrated extraction workflows to produce hydrophobic commodity and specialty chemicals from renewable feedstocks.
Expertise Areas
- Biofilm-based biomanufacturing
- Bioreactor design and scale-up
- Metabolic engineering
- Synthetic biology
Key Technologies
- Biofilm-forming continuous bioreactors
- Integrated solvent extraction with bioprocess
- Genetic engineering of non-model organisms
- Metabolic pathway engineering
News & Updates
Capra will demonstrate the ability of its platform to rapidly scale and manufacture biologically derived small molecule active pharmaceutical ingredients (APIs) under a $7.5 million, two-year project agreement awarded through the BioMaP-Consortium, leveraging AI and modular bioreactors.
Coverage highlighting Capra's innovative biomanufacturing technology and its impact on the industry.
Capra will demonstrate the ability of its platform to rapidly scale and manufacture biologically derived small molecule active pharmaceutical ingredients (APIs) under a $7.5 million, two-year project agreement awarded through the BioMaP-Consortium, leveraging AI and modular bioreactors.
Coverage highlighting Capra's innovative biomanufacturing technology and its impact on the industry.